Democrats push for stem cell vote in US Senate
By Reuters,
Reuters
| 05. 04. 2006
WASHINGTON (Reuters) - Senate Democrats sought on Thursday to jump-start a long-awaited debate on legislation to allow federal funding of embryonic stem cell research by considering it while it debates other health measures this month.
The Democrats sent a letter to Majority Leader Bill Frist asking him to add stem cells to what Republicans have dubbed "health week." Frist wants the Senate to consider other health legislation, possibly next week, on medical malpractice and small business insurance.
Despite a veto threat by President George W. Bush, the U.S. House of Representatives passed a bipartisan bill last year backing research on excess embryos that would otherwise be discarded by fertility clinics.
The Senate has not taken up the bill, Frist, a Tennessee Republican, broke with other conservatives to embrace it in a surprise move last summer.
"Further delay will mean more lost opportunities for new cures and new treatments," leading Democrats said in a letter to Frist to be made public on Thursday.
The letter to Frist from Senate Democratic leader Harry Reid of Nevada, stem cell bill co-sponsor Tom Harkin...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...
